There is 1 paper on CLI Frailty Index in aging research: 1 observational study in people.
1 paper studies it4 findings
“The CLI Frailty Index is a risk factor for 2-year AFS in CLI patients after revascularization.”
- Humans1
Effects
1Prognostic discrimination
upin humans1
1 study
Prognostic discrimination
upin humans1
CLI Frailty Index is linked with better prognostic discrimination in humans (compared with the modified Frailty Index in critical limb ischemia after revascularization) (AUC 0.72 versus 0.63; P = .01).
“The CLI Frailty Index area under the curve was 0.72 compared with 0.63 for the modified Frailty Index (P = .01).”
Humanscompared with the modified Frailty Index in critical limb ischemia after revascularizationn = 266
Journal of vascular surgery
Associations
330-day or hospital mortality
upin humans1HR 6.32
1 study
30-day or hospital mortality
upin humans1HR 6.32
CLI Frailty Index predicts 30-day or hospital mortality in humans (critical limb ischemia after infrapopliteal revascularization) (HR 6.32, 95% CI 1.43–43.7).
“Only the CLI Frailty Index was found to be a risk factor for morbidity (HR, 3.21; 95% CI, 1.45-7.27; P = .004) and 30-day or hospital mortality”
Humanscritical limb ischemia after infrapopliteal revascularization30 days or hospitalizationn = 266
Journal of vascular surgery
Morbidity
upin humans1HR 3.21
1 study
Morbidity
upin humans1HR 3.21
CLI Frailty Index predicts morbidity in humans (critical limb ischemia after infrapopliteal revascularization) (HR 3.21, 95% CI 1.45–7.27).
“Only the CLI Frailty Index was found to be a risk factor for morbidity (HR, 3.21; 95% CI, 1.45-7.27; P = .004)”
Humanscritical limb ischemia after infrapopliteal revascularizationn = 266
Journal of vascular surgery
Amputation-free survival
downin humans1HR 2.77
1 study
Amputation-free survival
downin humans1HR 2.77
CLI Frailty Index predicts amputation-free survival in humans (HR 2.77, 95% CI 1.78–4.32).
“The CLI Frailty Index is a risk factor for 2-year AFS in CLI patients after revascularization.”
Humanscritical limb ischemia after infrapopliteal revascularization; hazard ratio for the adverse endpoint2 yearsn = 266
Journal of vascular surgery